Celltrion
068270.KS
#839
Rank
NZ$51.88 B
Marketcap
NZ$226.25
Share price
-0.50%
Change (1 day)
9.10%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): NZ$4.37

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$4.41. In 2025 the company made an earnings per share (EPS) of NZ$5.40 an increase over its 2024 EPS that were of NZ$2.05.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.37-19.15%
2025NZ$5.40163.66%
2024NZ$2.05-53.73%
2023NZ$4.43-2.08%
2022NZ$4.52-11.72%
2021NZ$5.122.03%
2020NZ$5.0282.8%
2019NZ$2.7518.31%
2018NZ$2.32-36.33%
2017NZ$3.65161.25%
2016NZ$1.402.86%
2015NZ$1.3617.84%
2014NZ$1.155.87%
2013NZ$1.09-70.85%
2012NZ$3.73134.09%
2011NZ$1.5943.59%
2010NZ$1.1174.49%
2009NZ$0.64317.8%
2008NZ$0.15-71.7%
2007NZ$0.54